What is the role of the KRAS biomarker in NSCLC?

Listen to Beth Sandy MSN, CRNP, Thoracic Oncology Nurse Practitioner talk about the role of the KRAS biomarker in non-small cell lung cancer. She will explain how this biomarker drives cancer growth, the different types of variants, and introduce KRAS inhibiting targeted therapies that are in clinical trials.
Explore more genomics resources in our Genomics and Precision Oncology Learning Library. 

_{This resource was developed by ONS through a sponsorship from Amgen.}